EPM speaks to Marcus Michel, CEO of ACG Group’s Engineering Division in Mumbai, India about the biggest industry challenges, his love of technology and the effect Covid-19 has had on business.
Adam Tetz director of Worldwide Marketing for Peli BioThermal looks at how tracking technologies can support supply chain monitoring and help ensure the protection of pharma payloads.
Hannah Bailey, business development director of Intoware, explains how digitalisation is helping pharma manufacturers meet digital workflow challenges.
Dr Tracy Brown, head of Life Sciences and Healthcare at TÜV SÜD National Engineering Laboratory explores the advances being made to reduce medical error with improved infusion drug delivery.
EPM speaks to Spirax Sarco to understand the role steam systems play in pharma and how the company can help improve sustainability throughout the industry.
EPM speaks to Lonza to learn about how to ensure good bioavailability across compounds and which therapy areas are benefitting from targeted drug delivery.
George I’ons - head of Product Strategy and Insights at Owen Mumford Pharmaceutical Services takes a deep dive into the state of the connected drug delivery device industry.
Sahana Mollah, senior manager, Global BioPharma Collaboration & CE Tech Marketing at SCIEX looks at how antibody variants are helping researchers develop new medicines.
Peter Zipfell, product marketing manager at Thermo Fisher Scientific explains how better software can help pharmaceutical manufacturers keep their data accurate.
EPM speaks to Sophie Walton, group director of Academic Engagement, CPI, to learn about the Northern BioAccelerator Partnership, which was set up to stimulate investment in the North East’s bioscience sector.
Marc Brown, Jon Lenn and Charles Evans, from MedPharm, discuss the latest industry innovations, the benefits of automation and mitigating the risk of product failure in the development of topical products.
EPM speaks to Shorla Pharma’s CTO Orlaith Ryan about how the company is aiming to be a strong contender in the oncology market through therapies designed for women and children.
